The 5 Secrets Canadian Web Pharmacies Don't Want You To Know
#1: What's the difference between a Canadian retail pharmacy you can drive to over the border and a "Canadian online pharmacy" sending medicine in the mail? Click here to learn the secret.
#2: Does the medicine from a "Canadian online pharmacy" REALLY come from Canada and other safe countries? Learn where it really comes from.
#3: What's the REAL secret behind the rock-bottom prices that Canadian online pharmacies provide? Click here to find out.
#4: Who really protects consumers from fake medicines purchased from a Canadian online pharmacy? Learn who your protector is.
#5: Isn't the medicine I get from a "Canadian online pharmacy" just from the pile of medications that are price-fixed by the Canadian government? Learn the real source of those Canadian drugs.
Featured Story
Malaria Medication in Nigeria
by World Bank Photo via Flickr.
Chinese Medicine Manufacturer Steps Up To Ensure Patient Safety
Chinese pharmaceutical manufacturer Guilin Pharmaceuticals is rolling out SMS-text message codes on packaging to ensure authenticity of its antimalarial medication in Nigeria.
Guilin's artesunate meets world-wide quality assurance standards and has been pre-qualified by the World Health Organization (WHO). The Prequalification Programme applies unified standards of quality, safety and efficacy to medicinal products and includes manufacturing inspections, and evaluation of ingredients. Though the program is mainly used by UNAIDS and UNICEF to guide procurement, other agencies use it as a guide to determine safety at an international level, reports the WHO.
Now, purchasers of the medication can guard against purchasing counterfeit versions by scratching off a hidden identification code on drug packages. Patients can send the code via text message to a computer that will send back a safety message if the package is authentic, reports The Financial Times.
The service will be available to 50 million mobile subscribers in Nigeria. Eventually the program is expected to expand across Africa. Guilin has partnered with mPedigree Network, a West African company started by Ghanaian Bright Simons, reports The Ghana Business News. A competing collaboration between Sproxil and Bharti Airtel also helps legitimate pharmaceutical manufacturers provide a method of drug authentication that can be done on the consumer level, reports The Financial Times.
Guilin plans to expand the use of the technology across Africa. After Guilin begins its new roll out, Watson Global Pharmaceuticals will also begin using mPedigree Network's service for both antimalarial and antibiotic drugs, reports The Financial Times.
Simons told The Financial Times, “Given how quickly China is building a market-share in the global south pharmaceutical trade, this could represent a seismic shift in the fake medicines situation. My view is that other Chinese groups will also start to come to terms with the problem.”
MORE>>>FDA Releases Video on Counterfeit Detection Device 3 May 13, 2013
The FDA has released more information about their new counterfeit drug detection device, Counterfeit Detection Device 3 (CD-3). In this newly-released video, Nico Ranieri, the FDA research biologist who developed this new technology talks about how important such innovations are to patient safety.
In 2005, it first occurred to Nicolas Ranieri to try to use the type of ultra-violet light devices deployed in crime scene investigations in a hand-held counterfeit drug detection device. Up to that point, drug testing equipment was both delicate, expensive, and also required highly-trained scientists to perform the tests for fakes. Says Ranieri, “We wanted to find counterfeits, and we wanted to find them as fast as possible,” reports the FDA.
MORE>>>Fake Botox on the Rise in US as FDA Warnings and Recent Arrest Indicate
May 7, 2013
In 2012, the FDA sent over 350 warning letters to doctors advising them they may have purchased fraudulent or misbranded injectable drugs, including fake versions of Avastin, Botox, and two different osteoporosis treatments. Now the FDA has identified another batch of fake Botox that is currently being marketed to doctor via fax blast.
On April 26, 2013, the US Food and Drug Administration (FDA) posted a drug safety warning for healthcare practitioners, warning them that fraudulent versions of the anti-wrinkle treatment Botox are being marketed and sold in the US. The Botox is being sold by unlicensed suppliers, and has not been vetted within the secure U.S. supply chain. They state that the FDA “cannot confirm that the manufacture, quality, storage, and handling of these products follow U.S. standards. These fraudulent products are considered unsafe and should not be used."
MORE>>>Rx360 Launches Physician Education Campaign on the Risks of Counterfeit Drug Wholesalers
May 13, 2013
Rx360 has launched a new campaign educating healthcare providers to the risks of buying diverted and suspect products advertised directly to doctors' offices via fax blast, direct email and online marketing.
Lewis T. Kontnik, team lead for the education campaign, says, "Some of the recent problems with counterfeit and diverted medicines in the US, including the counterfeit versions of Avastin, resulted in part from a lack of awareness by physicians and medical practice administrators of the risks of counterfeit and diverted medicines. The ads of the professional diverters can appear tempting when they promise 'genuine' medicine and substantial discounts, however the facts are different and the consequences can be very serious."
MORE>>>PSM Supports HR 1919, 'Safeguarding America's Pharmaceuticals Act'
May 21, 2013
Dear Speaker Boehner and Chairman Upton:
On behalf of the Partnership for Safe Medicines (PSM), we write today in strong support of H.R. 1919, the “Safeguarding America’s Pharmaceuticals Act”.
PSM is a not for profit, consumer focused organization that seeks to keep Americans safe from counterfeit drugs through patient and healthcare provider education and awareness. In the US we work with a coalition of over 70 healthcare professional and patient groups to improve patients’ and their healthcare providers’ knowledge about where they obtain their medication, how they can save money safely, and how to safely identify licensed pharmaceutical distributors.
PSM strongly supports the creation of a national uniform track and trace or pedigree system that would allow all participants in the supply chain to verify a product’s history of sale.
MORE>>>Counterfeit Drug Incident Encyclopedia
- London Raid Finds $750K in Misbranded Drugs: April 23, 2013
- Chicago Pharmacist Charged with Substituting Chinese Counterfeits for Genuine Medication: April 18, 2013
- 4 Welsh Residents Sentenced in UK Counterfeit Drugs Case: March 27, 2013
- Portguese National Sentenced to 44 Months in Jail after $2.4 Million Worth of Unlicensed and Class C Drugs Seized by MHRA: February 25, 2013
- Brother of Lebanese State Minister Arrested in Counterfeit Drugs Case: February 15, 2013
- 7 Sentenced in China For Producing Toxic Gel Medicine Capsules: February 6, 2013
- 3rd Instance of Counterfeit Cancer Treatment Found in United States: February 5, 2013
- Puerto Rican Man Sentenced in US Counterfeit Drugs Case: January 28, 2013
- Canadian Citizen & Online Pharmacy Entrepreneur Sentenced to 4 Years in Counterfeit Drugs Case: January 9, 2013
- Fake Doctor Pleads Guilty to Practicing Without a License & Administering Unapproved Drugs in San Diego: October 19, 2012